BROSSARD, March 17, 2025 – Myriad Pharma, the division of Mantra Pharma specializing in the marketing of over-the-counter products, is expanding its representation network with two new partners: Laboratoire Modilac and La ligne J’ARRÊTE. These collaborations reinforce Myriad Pharma’s commitment to providing accessible and innovative health solutions while supporting pharmacies in their essential role in patient care.

Laboratoire Modilac

A leader in infant formula, Laboratoire Modilac has been delivering high-quality nutritional products since 1984. Through this partnership, Myriad Pharma will offer specialized nutritional solutions for infants and young children.

Approved by Health Canada, the product line includes Précision 1 (0-6 months) and Précision 2 (6-12 months), available at most pharmacies in Quebec. Modilac also provides Modilac Riz, a clinically proven formula designed for infants and young children with cow’s milk protein allergy and/or lactose intolerance^1,2,3. This product is covered by the RAMQ.

La ligne J’ARRÊTE

La ligne J’ARRÊTE is a free smoking cessation helpline managed by the Canadian Cancer Society – Quebec Division. As part of its mission, Myriad Pharma will promote this service in response to increasing pharmacy demand for effective addiction prevention tools. Research shows that individuals using La ligne J’ARRÊTE are three times more likely to quit smoking successfully. Key features of the service include:

• Motivational counseling from trained specialists
• Personalized support tailored to individual needs
• A non-judgmental approach
• Can be combined with pharmacological support
• Free, confidential, and bilingual
• Accessible via phone, text, or email⁴

Myriad Pharma is proud to support this initiative by making it available through its pharmacy network in Quebec.

« These partnerships reflect our commitment to supporting pharmacies in their central role in counseling and prevention. We are proud to contribute to improving access to innovative solutions for patients, in line with our mission to help provide better care for people », said Line Fecteau, General Manager of Myriad Pharma.

This announcement is part of Myriad Pharma’s broader growth strategy, strengthening its partner network to meet the evolving healthcare needs in Quebec.

For more information:

Line Fecteau
General Manager, Myriad Pharma
lfecteau@mantrapharma.ca
450 678 7088 | 438 862 2552

_________

1. Étude « GRITO », published in 2025 : Modilac Riz versus eHF (caséine) ; bébés APLV.
2. Étude Rechet et al., published in 2010 : Modilac Riz versus eHF (caséine) ; bébés APLV.
3. Étude Girard et al., published in 2010 : Modilac Riz chez les bébés en bonne santé
4. www.quebecsanstabac.ca/jarrete